Clinical Outcomes of the Oral Suspension vs Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections

BACKGROUND: Posaconazole is effective prophylaxis for invasive fungal infections (IFIs). We compared incidence of breakthrough IFI (bIFI) and early posaconazole discontinuation between patients receiving delayed-release tablet and oral suspension formulations. METHODS: This was a retrospective cohor...

詳細記述

保存先:
書誌詳細
出版年:Open Forum Infect Dis
主要な著者: Tallman, Gregory B, Furuno, Jon P, Noble, Brie N, Bubalo, Joseph S, Forrest, Graeme N, Lewis, James S, Bienvenida, Ana F, Holmes, Courtney A, Weber, Bo R, McGregor, Jessina C
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2017
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631689/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.039
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料